Serum Free Media Market Size, Share & Forecast Analysis


Posted February 26, 2024 by MadhuraTBRC

Global serum free media market size is expected to reach $2.49 Bn by 2028 at a rate of 11.1%, segmented as by media type, chinese hamster ovary (cho) cell media, protein expression media, immunology media, insect cell media, hybridoma media
 
The Serum Free Media Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Serum Free Media Market:
https://www.thebusinessresearchcompany.com/report/serum-free-media-global-market-report

According to The Business Research Company’s Serum Free Media Global Market Report 2024, The serum free media market size has grown rapidly in recent years. It will grow from $1.45 billion in 2023 to $1.63 billion in 2024 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to cell culture advancements, regulatory restrictions, demand for biopharmaceuticals, reduction in contamination risk.

The serum free media market size is expected to see rapid growth in the next few years. It will grow to $2.49 billion in 2028 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to bioprocessing expansion, cell therapy advancements, regulatory support, stem cell research, demand for vaccine production. Major trends in the forecast period include technological innovations, animal component-free solutions, customized media formulations, microcarrier culture systems, continuous bioprocessing.

The increasing prevalence of chronic diseases is expected to propel the growth of the serum-free media market going forward. Chronic diseases last for a year or longer and necessitate continuing medical care, restricting everyday activities, or both. Serum-free media allows researchers to optimize the media for the specific cell type used and to ensure that the cells grow under optimal conditions. Further, Researchers use serum-free media to produce cell types or perform specific applications without serum, which helps develop new therapies and treatments for chronic diseases. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, it was projected that by the year 2050, the number of individuals aged 50 years and older who have at least one chronic illness will surge by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Therefore, the increasing prevalence of chronic diseases is driving the growth of the serum-free media market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12588&type=smp

The serum free media market covered in this report is segmented –

1) By Media Type: Chinese Hamster Ovary (CHO) Cell Media, Protein Expression Media, Immunology Media, Insect Cell Media, Hybridoma Media, Stem Cell Media, Chemically Defined Media
2) By Application: Biopharmaceutical Production, Tissue Engineering And Regenerative Medicine
3) By End-User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Centers, Other End-Users

Product innovation has emerged as a key trend gaining popularity in the serum-free media market. Major companies operating in the serum-free media market are concentrating on creating innovative products to strengthen their position in the market. For instance, in March 2021, Thermo Fisher Scientific Inc., a US-based medical equipment provider, launched Gibco CTS OpTmizer Pro Serum-Free Media (SFM). It is a first-of-its-kind media solution targeting the metabolism of healthy donor cells, making it the ideal choice for developing allogeneic, over-the-counter cell treatments. Using allogeneic processes, Gibco CTS OpTmizer Pro generates and multiplies human T lymphocytes (T-cells) for cell therapy developers.

The serum free media market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Major Players:

Thermo Fisher Scientific Inc.
Danaher Corp.
Merck KgaA
FUJIFILM Irvine Scientific Inc.
GE HealthCare Technologies Inc
Corning Inc.
Related Reports:

https://goodprnews.com/scuba-diving-equipment-market-share-and-current-insights/
https://goodprnews.com/thin-boiling-starch-market-growth/
https://goodprnews.com/vehicle-conversion-market-analysis-trends-and-forecast/
https://topprnews.com/scuba-diving-equipment-market-statistics-forecast/
https://topprnews.com/thin-boiling-starch-market-sales-consumption-demand/
https://topprnews.com/vehicle-conversion-market-size-share-revenue-trends/


Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]


Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By tbrc
Country United Kingdom
Categories Biotech
Last Updated February 26, 2024